Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Filed Chapter 11
Inv. presentation
Quarterly results
Appointed director
CC transcript
HELICOS BIOSCIENCES CORP (HLCS) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/11/2013 SC 13G/A Versant Affiliates Fund II-A, LP reports a 18.8% stake in Helicos Biosciences Corporation
12/10/2012 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter to Securities and Exchange Commission from PricewaterhouseCoopers LLP"
11/15/2012 8-K Quarterly results
11/15/2012 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
09/06/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/31/2012 8-K Other Events
08/29/2012 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Letter Agreement re: Risk Premium Agreement, by and among the Company and each of the Lenders identified therein"
08/14/2012 10-Q Quarterly Report for the period ended June 30, 2012
08/06/2012 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "License Agreement"
05/14/2012 10-Q Quarterly Report for the period ended March 31, 2012
04/17/2012 10-K/A Annual Report for the period ended December 31, 2011 [amend]
04/10/2012 8-K Form 8-K - Current report
03/30/2012 10-K Annual Report for the period ended December 31, 2011
03/09/2012 8-K Other Events
02/10/2012 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/10/2012 8-K Form 8-K - Current report
12/01/2011 8-K Form 8-K - Current report
11/16/2011 10-Q/A Quarterly Report for the period ended September 30, 2011 [amend]
11/14/2011 10-Q Quarterly Report for the period ended September 30, 2011
11/09/2011 4 Form 4 - Statement of changes in beneficial ownership of securities
09/22/2011 8-K Form 8-K - Current report
09/13/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/30/2011 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Helicos BioSciences Expands Its License with Arizona Technology Enterprises Covering Next Generation Sequencing; New Patents Continue to Issue CAMBRIDGE, Mass., August 30, 2011 — Helicos BioSciences Corporation announced today that it has amended its existing license with Arizona Technology Enterprises to include all activities that fall within the scope of, or constitute the practice of, the licensed patents, and gives Helicos full and unencumbered rights to the associated intellectual property. The license, which gives Helicos rights to several patents covering sequencing-by-synthesis methods, now expressly includes detection methods that do not rely on optically-labeled nucleotides. “The expanded license is another example of Helicos's successful strategy of systematically expanding its..."
08/12/2011 10-Q Quarterly Report for the period ended June 30, 2011
06/30/2011 8-K Form 8-K - Current report
05/13/2011 10-Q Quarterly Report for the period ended March 31, 2011
04/29/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/31/2011 10-K Annual Report for the period ended December 31, 2010
03/01/2011 8-K Form 8-K - Current report
02/14/2011 SC 13G/A HELICOS BIOSCIENCES CORP reports a 19.8% stake in Helicos Biosciences Corporation
01/25/2011 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
01/21/2011 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
01/05/2011 4 Moore Jeffrey R. (SVP, CFO & Treasurer) has filed a Form 4 on HELICOS BIOSCIENCES CORP
12/09/2010 SC 13D/A AGTC ADVISORS FUND LP reports a 19.9% stake in Helicos BioSciences Corporation
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy